Skip to main content
. Author manuscript; available in PMC: 2019 May 20.
Published in final edited form as: Brain Behav Immun. 2018 Jun 11;73:66–84. doi: 10.1016/j.bbi.2018.06.010

Table 2.

NLRP3 activated cytokines and other major cytokines in psychiatric disorders: a list of inflammatory cytokines in the NLRP3 priming pathway sampled in patients with major depressive disorder and bipolar disorder.

Psychiatric Disorder Inflammatory Protein (+/−) Sample-Type Source
Major Depressive Disorder (+) Il-1β CSF (Levine et al., 1999)
(+) Il-1β Serum (Anisman et al., 1999; Howren et al., 2009; Maes et al., 1993; Owen et al., 2001; Thomas et al., 2005)
(+) IL-18 Serum (Kokai et al., 2002; Merendino et al., 2002),
(+) Il-6 Serum (Howren et al., 2009; Lanquillon et al., 2000; Sluzewska, 1999)
(−) Il-6 CSF (Levine et al., 1999)
(+) TNF-α Serum (Anisman et al., 1999; Hestad et al., 2003; Lanquillon et al., 2000)
Bipolar Disorder (+) IL-1β Post-Mortem Tissue (Rao et al., 2010)